188 related articles for article (PubMed ID: 27233367)
21. National Trends in Hospitalization for Fever and Neutropenia in Children with Cancer, 2007-2014.
Lekshminarayanan A; Bhatt P; Linga VG; Chaudhari R; Zhu B; Dave M; Donda K; Savani S; Patel SV; Billimoria ZC; Bhaskaran S; Zaid-Kaylani S; Dapaah-Siakwan F; Bhatt NS
J Pediatr; 2018 Nov; 202():231-237.e3. PubMed ID: 30029861
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of pulmonary tuberculosis in France. Can the hospital discharge database be a reliable source of information?
Girard D; Antoine D; Che D
Med Mal Infect; 2014 Dec; 44(11-12):509-14. PubMed ID: 25455077
[TBL] [Abstract][Full Text] [Related]
23. Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
Weycker D; Barron R; Kartashov A; Legg J; Lyman GH
J Oncol Pharm Pract; 2014 Jun; 20(3):190-8. PubMed ID: 23824496
[TBL] [Abstract][Full Text] [Related]
24. Vulvar and vaginal cancers and dysplasia in France--an analysis of the hospital medical information system (PMSI) database.
Rémy V; Mathevet P; Vainchtock A
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):210-4. PubMed ID: 19735968
[TBL] [Abstract][Full Text] [Related]
25. Comparing the Incidence of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel and the Generic Formulations.
Faqeer NA; Mashni O; Dawoud R; Rumman A; Hanoun E; Nazer L
J Clin Pharmacol; 2017 Feb; 57(2):275-279. PubMed ID: 27479828
[TBL] [Abstract][Full Text] [Related]
26. Length of stay and mortality associated with febrile neutropenia among children with cancer.
Basu SK; Fernandez ID; Fisher SG; Asselin BL; Lyman GH
J Clin Oncol; 2005 Nov; 23(31):7958-66. PubMed ID: 16258096
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors for Febrile Neutropenia in Children With Solid Tumors Treated With Cisplatin-based Chemotherapy.
Castelán-Martínez OD; Rodríguez-Islas F; Vargas-Neri JL; Palomo-Colli MA; López-Aguilar E; Clark P; Castañeda-Hernández G; Rivas-Ruiz R
J Pediatr Hematol Oncol; 2016 Apr; 38(3):191-6. PubMed ID: 26907640
[TBL] [Abstract][Full Text] [Related]
28. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy.
Caggiano V; Weiss RV; Rickert TS; Linde-Zwirble WT
Cancer; 2005 May; 103(9):1916-24. PubMed ID: 15751024
[TBL] [Abstract][Full Text] [Related]
29. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
30. Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department.
Keng MK; Thallner EA; Elson P; Ajon C; Sekeres J; Wenzell CM; Seastone DJ; Gallagher EM; Weber CM; Earl MA; Mukherjee S; Pohlman B; Cober E; Foster VB; Yuhas J; Kalaycio ME; Bolwell BJ; Sekeres MA
J Oncol Pract; 2015 Nov; 11(6):450-5. PubMed ID: 26220930
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005-2010).
Casez P; Fauconnier J; Jorgensen L; Gutterman EM; Gray S; Munson S; Dartois N; Gaillat J
Med Mal Infect; 2015; 45(11-12):446-55. PubMed ID: 26607227
[TBL] [Abstract][Full Text] [Related]
32. Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.
Delebarre M; Dessein R; Lagrée M; Mazingue F; Sudour-Bonnange H; Martinot A; Dubos F
J Infect; 2019 Aug; 79(2):95-100. PubMed ID: 31228471
[TBL] [Abstract][Full Text] [Related]
33. [Acute and post-acute hospitalizations for stroke in France: recent improvements (2007-2009)].
de Peretti C; Nicolau J; Tuppin P; Schnitzler A; Woimant F
Presse Med; 2012 May; 41(5):491-503. PubMed ID: 22401964
[TBL] [Abstract][Full Text] [Related]
34. Risk of mortality in patients with cancer who experience febrile neutropenia.
Lyman GH; Michels SL; Reynolds MW; Barron R; Tomic KS; Yu J
Cancer; 2010 Dec; 116(23):5555-63. PubMed ID: 20715160
[TBL] [Abstract][Full Text] [Related]
35. Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors.
Weycker D; Li X; Edelsberg J; Barron R; Kartashov A; Xu H; Lyman GH
J Oncol Pract; 2015 Jan; 11(1):47-54. PubMed ID: 25491042
[TBL] [Abstract][Full Text] [Related]
36. [Post chemoterapy febrile neutropenia. Length of stay and experience in our population].
Pérez-Heras Í; Raynero-Mellado RC; Díaz-Merchán R; Domínguez-Pinilla N
An Pediatr (Engl Ed); 2020 Mar; 92(3):141-146. PubMed ID: 31239190
[TBL] [Abstract][Full Text] [Related]
37. Association between serum levels of MASP-2 and neutropenic febrile attacks in children with leukemia.
Nazari S; Ebrahimi M; Abdollah Gorji F; Abadi A; Fahimzad A
Arch Iran Med; 2012 Oct; 15(10):625-8. PubMed ID: 23020538
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.
Lyman GH; Abella E; Pettengell R
Crit Rev Oncol Hematol; 2014 Jun; 90(3):190-9. PubMed ID: 24434034
[TBL] [Abstract][Full Text] [Related]
39. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
[TBL] [Abstract][Full Text] [Related]
40. Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy.
Moreira-Pinto J; Leão I; Palmela C; Branco F; Godinho J; Simões P; Leal-Costa L; Lopes F; Faria A; Casa-Nova M; Escária A; Costa F; Galvão I; Teixeira J; Passos-Coelho JL
Oncol Res Treat; 2020; 43(11):605-612. PubMed ID: 32818937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
